4CPS-356 Cost minimisation analysis of the use of nivolumab and pembrolizumab
B Del Rosario García
◽
F Gutiérrez Nicolás
◽
JA Morales Barrios
◽
MM Viña Romero
◽
E Ramos Santana
◽
...
2018 ◽
Vol 21
◽
pp. S16
◽
2014 ◽
Vol 121
(12)
◽
pp. 1546-1553
◽
C Teljeur
◽
M O'Neill
◽
PS Moran
◽
P Harrington
◽
M Flattery
◽
...
2018 ◽
Vol 256
(11)
◽
pp. 2181-2189
◽
Kelvin Ngan
◽
Ewan Fraser
◽
Sophie Buller
◽
Alex Buller
G Harty
◽
C Treharne
◽
S Budhia
◽
SL Wong
AB Guisado Gil
◽
M Muñoz Burgos
◽
FJ Bautista Paloma
◽
FJ Garcia Hernandez
◽
B Santos Ramos
2004 ◽
Vol 7
(6)
◽
pp. 749
2009 ◽
Vol 33
(4)
◽
pp. 208-216
2012 ◽
Vol 15
(7)
◽
pp. A663
H. Kim
◽
L. Gurrin
◽
D. Liew
David T Arnold
◽
Louise M Bentham
◽
Ruth P Jacob
◽
Richard J Lilford
◽
Alan J Girling
2005 ◽
Vol 8
(6)
◽
pp. A81
T Heinen-Kammerer
◽
K Motzkat
◽
R Rychlik